Sulindac Tablet
Product Images NDC 72789-374

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sulindac (NDC 72789-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789374 Label (72789374)

Label for Sulindac 200 mg oral tablets by PD-Rx Pharmaceuticals, Inc. The label indicates a 100-tablet container, with storage instructions at 20° to 25°C and a debossed tablet code MP116. It includes warnings to keep out of children’s reach, a tamper-evident seal note, and manufacturing information by Frontida BioPharm, Inc. in Philadelphia, PA.*

FDA Label Image

Structure (Sulindac 01)

Chemical structure diagram showing the conversion among sulindac and its sulfone and sulfide forms. The diagram depicts the molecular structures with annotations indicating sulfide, sulfoxide (sulindac), and sulfone forms, illustrating the reversible metabolic transformation between these three states.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.